Nutex Health (NASDAQ:NUTX) Stock Price Down 4.9% – Here’s What Happened

by · The Markets Daily

Nutex Health Inc. (NASDAQ:NUTX – Get Free Report)’s stock price dropped 4.9% on Tuesday . The stock traded as low as $177.74 and last traded at $170.8370. Approximately 1,562 shares traded hands during mid-day trading, a decline of 99% from the average daily volume of 152,476 shares. The stock had previously closed at $179.55.

Analysts Set New Price Targets

A number of analysts have recently issued reports on the stock. Weiss Ratings restated a “hold (c)” rating on shares of Nutex Health in a report on Monday, December 15th. Wall Street Zen raised Nutex Health from a “buy” rating to a “strong-buy” rating in a research note on Friday, November 28th. Finally, Maxim Group set a $205.00 target price on Nutex Health and gave the company a “buy” rating in a research report on Tuesday, August 26th. Two equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. According to MarketBeat.com, Nutex Health currently has a consensus rating of “Moderate Buy” and a consensus target price of $252.50.

Check Out Our Latest Stock Report on NUTX

Nutex Health Trading Down 7.6%

The firm has a market cap of $1.17 billion, a price-to-earnings ratio of 8.89 and a beta of -0.03. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.20 and a quick ratio of 3.18. The company’s 50 day simple moving average is $132.53 and its 200 day simple moving average is $113.28.

Nutex Health (NASDAQ:NUTX – Get Free Report) last released its earnings results on Tuesday, November 18th. The company reported $7.76 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($5.43) by $13.19. Nutex Health had a return on equity of 37.44% and a net margin of 11.62%.The firm had revenue of $243.99 million during the quarter, compared to analyst estimates of $221.93 million.

Insider Buying and Selling at Nutex Health

In other news, CFO Jon Christian Bates bought 750 shares of Nutex Health stock in a transaction that occurred on Tuesday, November 25th. The shares were purchased at an average price of $136.71 per share, with a total value of $102,532.50. Following the completion of the acquisition, the chief financial officer directly owned 5,638 shares in the company, valued at $770,770.98. The trade was a 15.34% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 36.92% of the company’s stock.

Institutional Investors Weigh In On Nutex Health

A number of large investors have recently modified their holdings of NUTX. Topline Capital Management LLC raised its holdings in shares of Nutex Health by 80.0% in the 3rd quarter. Topline Capital Management LLC now owns 556,567 shares of the company’s stock valued at $57,505,000 after purchasing an additional 247,436 shares in the last quarter. Pertento Partners LLP acquired a new stake in shares of Nutex Health during the 3rd quarter worth about $27,940,000. Vanguard Group Inc. raised its holdings in Nutex Health by 12.7% during the third quarter. Vanguard Group Inc. now owns 214,954 shares of the company’s stock worth $22,209,000 after purchasing an additional 24,275 shares in the last quarter. American Century Companies Inc. lifted its position in Nutex Health by 39.9% in the second quarter. American Century Companies Inc. now owns 104,063 shares of the company’s stock valued at $12,955,000 after acquiring an additional 29,704 shares during the last quarter. Finally, Marshall Wace LLP boosted its position in shares of Nutex Health by 333.4% in the 2nd quarter. Marshall Wace LLP now owns 94,548 shares of the company’s stock valued at $11,770,000 after purchasing an additional 72,734 shares during the period. 5.32% of the stock is owned by hedge funds and other institutional investors.

About Nutex Health

(Get Free Report)

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.

See Also